Get notified of page updates

Policy Archive

Fraud Alert! Genetic test scams are a growing problem.

Genetic Counseling & Testing

September 27, 2019 - Federal law enforcement agencies recently charged 35 individuals associated with dozens of telemedicine companies and cancer genetic testing laboratories for fraudulent genetic testing and Medicare billing practices. Scams are a growing problem. If you are considering DNA/genetic testing, there is important information that you should know first.

See this recent fraud alert issued by the Office of Inspector General and learn how you can protect yourself from fraud, misinformation, and harm.

Scam Alert SignThere is a flood of information available about genetic tests for cancer risk in the media, and even at community events, such as health fairs and senior centers. Genetic testing can provide important, life-saving information when done in the right way. If you are considering genetic testing to learn more about your hereditary cancer risk, or if you have already received genetic test results, consider speaking with a genetic counselor, doctor or other health care provider who has advanced training in genetics. This is the most reliable way to obtain and understand information about your risk.

View a detailed graphic of the fraud scheme

Watch this brief video about genetic testing fraud.

Read the FORCE Blogs on this issue for more information and perspective: 

Filing a Complaint

You have a right to know the name of the lab performing your genetic testing. Beware of representatives marketing tests in community settings or selling genetic tests for unnamed labs. Genetic tests are currently regulated by the FDA and CLIA. When ordering lab work such as a genetic test, health care providers typically order them through a trusted, CLIA-certified lab, which is regularly evaluated for quality assurance.

The FDA aims to ensure that test marketing materials and claims are accurate, and that they address the information needs of the approved audience—health care providers or the public. If you have concerns or a complaint about a laboratory, you or your health care provider can file a complaint.

CLIA
All clinical laboratory testing performed on humans in the U.S. (except in clinical trials and basic research) is overseen by the Clinical Laboratory Improvement Amendments (CLIA).

If you have concerns or want to file a complaint against a lab that conducted genetic testing, you or your health care provider should reach out to your state CLIA contact

All other questions or concerns about the CLIA program should be submitted to LabExcellence@cms.hhs.gov

FDA
The Food and Drug Administration (FDA) also tracks adverse (negative) events and concerns about laboratory tests through MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Patients or health care providers can report adverse events to the FDA.

Take Action Now BECOME AN ADVOCATE 2022 Priorities Advocacy Archive Public Policy Initiatives

News Briefs

12/6/2022 - Joined a broad range of stakeholders to urge Appropriations leaders to pass the FY23 Omnibus spending bill, and to include boosted funding for the National Institutes of Health (NIH) and our nation’s other research agencies.

11/28/2022 - Asked congressional leadership to include the Access to Genetic Counselor Services Act (H.R.2144/S.1450) in a year-end legislative package so that Medicare beneficiaries can better access genetic counseling services.

11/21/2022 - Joined the Defense Health Research Consortium in encouraging congressional leaders to enact the FY23 Defense Appropriations Act, to ensure full funding of the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs (CDMRP).

11/2/2022 - Urged congressional leaders to prioritize the Metastatic Breast Cancer Access to Care Act (H.R.3183/S.1312), which eliminates waiting periods for SSDI benefits and for Medicare coverage for individuals with metastatic breast cancer.

More